Science |Arcus Biosciences
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
October 21, 2026 · 4:22 PM · HAYWARD, Calif.
Arcus Biosciences, Inc. (NYSE: RCUS), a late clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for the treatment of cancer and immune diseases, today announced that it has commenced an underwritten public offering of its common stock. All of the shares of common stock are being offered by Arcus Biosciences. In addition, Arcus Biosciences intends to grant the underwriters a 30-day option to purchase...
- PublishedOctober 21, 2026 · 4:22 PM
- LocationHAYWARD, Calif.
- IndustryScience
- LanguageEN
Published by Business Wire. Read the original announcement for the full release.
Read the full announcement →